The incidence of Human Papillomavirus (HPV)–associated oropharyngeal cancers—tumors of the back of the mouth and throat—is ...

A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.

Many diseases are caused by dysfunctional gene expression that leads to too much or too little of a given protein. Efforts to ...

A major new study has revealed that the genes we inherit at birth play a much larger role in cancer than previously ...

The DecisionDx-Melanoma test accurately identifies low sentinel lymph node risk in melanoma, according to the DECIDE study.

Cancer drugs that inhibit CDK7 rapidly shut down pathways responsible for cell proliferation within minutes. For organs to ...

New research has revealed that Schistosoma haematobium (S. haematobium), a parasitic infection affecting millions globally, ...

Pancreatic cancer is one of the most aggressive cancers and has one of the lowest survival rates-only 10% after five years.

The incidence of Human Papillomavirus (HPV)-associated oropharyngeal cancer tumors of the back of the mouth and throat is rising. If caught early, ...

City of Hope researchers demonstrate proof of concept for a novel targeted therapy for pancreatic cancer, exploiting transcription-replication conflicts to combat treatment resistance.

Researchers discover that inflammation and aging contribute to non-viral liver cancer development. Green tea's role in reversing some of the pathway dysregulation that may contribute to the cancer ...

A newly presented study has uncovered troubling molecular changes in the cervix associated with a common parasitic infection, ...